Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Bal Pharma In Jv Deal With Australian Firm

Bal Pharma In Jv Deal With Australian Firm

Chemical Weekly 2018-03-21

Melbourne-based Akaal Pharma has entered into joint venture with Bengaluru-based Bal Pharma. As a part of this jv, the venture called AB VET, will be funded by Bal Pharma to develop Akaal Pharma’s intellectual property (IP) in the veterinary field, the company said in a statement. The first veterinary indication will be against Atopic Dermatitis in dogs, wherein Akaal’s ABV-119 is used to treat them.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.